Online tool for monitoring adverse events in patients with cancer during treatment (eRAPID): field testing in a clinical setting.

Lorraine WarringtonKate L AbsolomPatricia HolchAndrea GibsonBeverly ClaytonGalina Velikova

Published in: BMJ open (2019)

The field testing generated valuable results used to guide refinement of eRAPID prior to formal intervention evaluation. Feedback indicated that eRAPID has the potential to improve patients' self-efficacy, knowledge and confidence with managing symptoms during treatment. A large-scale RCT is underway with data collection due to finish in October 2018.

Keyphrases

end stage renal disease
ejection fraction
randomized controlled trial
chronic kidney disease
healthcare
peritoneal dialysis
electronic health record
machine learning
big data
climate change
sleep quality
artificial intelligence